Determinants of Neurocognitive Impairment in HIV in a Cohort of Patients on Antiretroviral Therapy Followed in Bangui (Central African Republic) — Oak Academic Publishing
Research ArticleOpen AccessGoogle Scholar indexed
Determinants of Neurocognitive Impairment in HIV in a Cohort of Patients on Antiretroviral Therapy Followed in Bangui (Central African Republic)
Neurology Department, Hôpital de l’Amitié de Bangui, Bangui, Central African Republic
,
Department of Infectious and Tropical Diseases, Hôpital de l’Amitié de Bangui, Bangui, Central African Republic
,
Université des Sciences de la Santé, Libreville, Gabon
,
Neurology Department, Hôpital de l’Amitié de Bangui, Bangui, Central African Republic
,
Faculté des Sciences de la Santé, Université de Bangui, Bangui, Central African Republic
,
Hôpital de Jour, Centre National Hospitalier Universitaire de Bangui, Bangui, Central African Republic
1 Neurology Department, Hôpital de l’Amitié de Bangui, Bangui, Central African Republic
2 Department of Infectious and Tropical Diseases, Hôpital de l’Amitié de Bangui, Bangui, Central African Republic
3 Université des Sciences de la Santé, Libreville, Gabon
4 Neurology Department, Hôpital de l’Amitié de Bangui, Bangui, Central African Republic
5 Faculté des Sciences de la Santé, Université de Bangui, Bangui, Central African Republic
6 Hôpital de Jour, Centre National Hospitalier Universitaire de Bangui, Bangui, Central African Republic
Infection with HIV is one of the deadliest epidemics of our time and its type is widespread in the Central African Republic. It is frequently accompanied by neurological complications. Objective: To contribute to a better understanding of neurocognitive disorders in patients living with HIV (PLHIV) in Bangui, and to identify associated factors using the International HIV Dementia Scale (IHDS) as a screening tool. We conducted a descriptive and analytical cross-sectional study from 1 December 2014 to 30 January 2015, in a cohort of patients seen on one of the supported sites in Bangui. A total of 400 patients were received in follow-up visit during the study period of which 244 met the inclusion criteria. The prevalence of neurocognitive disorders was 25%, 95% CI [19.70 - 30.92]. The mean age of subjects was 42.77 ± 9.58 with extremes ranging from 24 - 64 years. The sex ratio (F/M) was 4.5 in. The average score for different tests was 10.93 ± 1.13 with extremes of 7 and 12. The disorder was more about the gestural sequence. Determinants of neurocognitive disorders in the cohort were older age and lower educational level (p < 0.05). It is useful to conduct further studies to confirm these results by combining a battery of neuropsychological tests to recommend this test for all the support sites of PLHIV in the country.
Onusida (2013) Rapport sur l’épidémie mondiale du sida.
Fonds des Nations Unis pour la Population., UNFPA/Bangui et ICF International (2012) Prévalence de l’infection à VIH et facteurs associés en République Centrafricaine en 2010. Calverton Maryland.
Levy, R.M., Bredesen, D.E. and Roserblum, M. (1988) Opportunistic Central Nervous System Pathology in Patients with AIDS. Ann Neural, 23, 7-12. http://dx.doi.org/10.1002/ana.410230706
Davis, L.E., Hjelle, B.L., Miller, V.E., Palmer, D.L., Llewellyn, A.L. and Merlin, T.L. (1992) Early Viral Brain Invasion in Iatrogenic Human Immunodeficiency Virus Infection. Neurology, 42, 1736-1739. http://dx.doi.org/10.1212/WNL.42.9.1736
Robertson, K.R., Smurzynski, M., Parsons, T.D., Wu, K., Bosch, R.J., Wu, J., et al. (2007) The Prevalence and Incidence of Neurocognitive Impairment in the HAART Era .AIDS, 21, 1915-1921. http://dx.doi.org/10.1097/QAD.0b013e32828e4e27
McArthur, J.C. (2004) Attenuated Central Nervous System Infection in Advanced HIV/AIDS with Combination Antiretroviral Therapy. Archives of Neurology, 61, 1687-1696. http://dx.doi.org/10.1001/archneur.61.11.1687
Heaton, R.K., Clifford, D.B., Franklin Jr., D.R., Woods, S.P., Ake, C. and Vaida, F., et al. (2010) HIV-Associated Neurocognitive Disorders Persist in the Era of Potent Antiretroviral Therapy. Neurology, 75, 2052-2094. http://dx.doi.org/10.1212/WNL.0b013e318200d727
Cherner, M., Masliah, E., Ellis, R.J., Marcotte, T.D., Moore, D.J., Grant, I., et al. (2002) Neurocognitive Dysfunction Predicts Post Mortem Findings in HIV Encephalopathy. Neurology, 59, 1563-1567. http://dx.doi.org/10.1212/01.WNL.0000034175.11956.79
Nath, A. and Berger, J. (2004) HIV Dementia. CNS Infection, 6, 139-151. http://dx.doi.org/10.1007/s11940-004-0023-6
Antinori, A., Arendt, G., Becker, J.T., Brew, B.J., Byrd, D.A., Cherner, M., et al. (2007) Updated Research Nosology for HIV-Associated Neurocognitive Disorders. Neurology, 69, 1789-1799. http://dx.doi.org/10.1212/01.WNL.0000287431.88658.8b
Robertson, K.R., Nakasujja, N., Wong, M., Musisi, S., Katabira, E., Parsons, T.D., et al. (2007) Pattern of Neuropsychological Performance among HIV Positive Patients in Uganda. BMC Neurology, 7, 8. http://dx.doi.org/10.1186/1471-2377-7-8
Hinkin, C.H., Hardy, D.J., Mason, K.I., Castellon, S.A., Durvasula, R.S., et al. (2004) Medication Adherence in HIV-Infected Adults: Effect of Patient Age, Cognitive Status, and Substance Abuse. AIDS, 18, 19-25. http://dx.doi.org/10.1097/00002030-200401001-00004
Fonds des Nations Unis pour la population (2010) Prévalence de l’infection à VIH et facteurs associés en RCA. Mics-4 RCA.
Organisation Mondiale de la Santé (2011) Le VIH en Afrique subsaharienne, rapport de situation. http://www.who.int/about/licensing/copyright_from/en/index.html
Lawler, K., Mosepele, M., Ratcliffe, S., Seloilwe, E., Steele, K., Nthobatsang, R., et al. (2010) Neurocognitive Impairment among HIV-Positive Individuals in Botswana: A Pilot Study. Journal of the International AIDS Society, 13, 15-23. http://dx.doi.org/10.1186/1758-2652-13-15
Lopardo, G., Bissio, E., Iannella, M.D., Crespo, A.D., Garone, D. and Cassetti, L. (2009) Good Neurocognitive Performance Measured by the International HIV Dementia Scale in Early HIV-1 Infection. Journal of Acquired Immune Deficiency Syndromes, 52, 488-492. http://dx.doi.org/10.1097/QAI.0b013e3181b06348
Alperovitch, A., Schwarzinger, M., Dufouil, C., Dartigues, J.F., Ritchie, K. and Tzourio, C. (2004) Vers une prévention de la démence ? Revue Neurologique, 160, 256-260. http://dx.doi.org/10.1016/S0035-3787(04)70900-5
Moulignier, A. (2006) Atteintes du système nerveux central et infection par le VIH-1. Revue Neurologique, 162, 22-42. http://dx.doi.org/10.1016/S0035-3787(06)74980-3
Organisation Mondiale de la Santé (2008) VIH/Sida et santé mentale. OMS Conseil exécutif.
Poissonet, A. (2008) Les tests cognitifs: Eléments de diagnostic et de suivi: Pourquoi et comment traiter un patient agé dément ? Réseau de Santé Paris Nord, Paris.
Power, C., Selnes, O.A., Grim, J.A. and McArthur, J.C. (1995) HIV Dementia Scale: A Rapid Screening Test. Journal of Acquired Immune Deficiency Syndrome and Human Retrovirology, 8, 273-278. http://dx.doi.org/10.1097/00042560-199503010-00008
Sacktor, N.C., Wong, M., Nakasujja, N., Skolasky, R.L., Selnes, O.A., Seggane, M., et al. (2005) The International HIV Dementia Scale: A New Rapid Screening Test for HIV Dementia. AIDS, 19, 1367-1374.
Bottiggi, K.A., Chang, J.J., Schmitt, F.A., Avison, M.J., Mootoor, Y., Nath, A., et al. (2007) The HIV Dementia Scale: Predictive Power in Mild Dementia and HAART. Journal of the Neurological Sciences, 260, 11-15. http://dx.doi.org/10.1016/j.jns.2006.03.023
Rodrigues, R.A., Oliviera, R.L., Grinsztejn, B. and Silva, M.T.T. (2013) Validity of the International HIV Dementia Scale in Brazil. Arquivos de Neuro-Psiquiatria, 71, 376-378. http://dx.doi.org/10.1590/0004-282x20130042
Joska, J.A., Westgarth-Taylor, J., Hoare, J., Thomas, K.G.F., Paul, R., Myer, L., et al. (2011) Validity of the International HIV Dementia Scale in South Africa. AIDS Patient Care and STDS, 25, 95-101. http://dx.doi.org/10.1089/apc.2010.0292
Mbelesso, P., Tabo, A., Guerchet, M., Mouanga, A.M., Bandzouzi, B., Houinato, D., et al. (2012) Epidémiologie des démences chez les personnes agées dans le troisième arrondissement de la ville de Bangui (République Centrafricaine). Bulletin de la société de pathologie exotique, 105, 388-395. http://dx.doi.org/10.1007/s13149-012-0247-8
Njamnshi, A.K., Djientcheu, V.P., Fonsah, J.Y., Yepnjio, F.N., Njamnshi, D.M. and Muna, W.F. (2008) The International HIV Dementia Scale Is a Useful Screening Tool for HIV-Associated Dementia/Cognitive Impairment in HIV-Infected Adults in Yaoundé-Cameroon. Journal of Acquired Immune Deficiency Syndromes, 49, 393-397. http://dx.doi.org/10.1097/QAI.0b013e318183a9df
Bonnave, N. (2011) Dépistage par l’international hiv dementia scale des troubles neurocognitifs parmi les patients séropositifs au VIH de l’ouest guyanais. Thèse de doctorat en médecine, Université de Guyane, Cayenne.
Moulignier, A. (2007) Le complexe démentiel associé au VIH: Aspect particuliers chez les sujets agés. Psychologie & NeuroPsychiatrie du vieillissement, 5, 193-207.
Bonnet, F.A.H. and Bruyand, M. (2009) High Prevalence of Mild Neurocognitive Disorders in HIV-Infected Patients. ANRS CO3 Aquitaine Cohort 2009, 474.
Oshinaike Olajumoke, O., Akinbami, A., kinsegun, A., Ojo Oluwadamilola, O., Ojini, I.F., Okubadejo, U.N., et al. (2012) Comparison of the Minimental State Examination Scale and the International HIV Dementia Scale in Assessing Cognitive Function in Nigerian HIV Patients on Antiretroviral Therapy. AIDS Research and Treatment, 2012, 1-6. http://dx.doi.org/10.1155/2012/581531
Brew, B.J. (2004) Evidence of a Change in AIDS Dementia Complex in the Era of Highly Active Antiretroviral Therapy and the Possibility of New Forms of AIDS Dementia Complex. AIDS, 18, S75-S78. http://dx.doi.org/10.1097/00002030-200401001-00011
Golden, C.J., Sweet, J., Hammeke, T., Purisch, A., Graber, B. and Osmon, D. (1980) Factor Analysis of Luria-Nebraska Neuropsychological Battery. I. Motor, Rhythm, and Tactile Scales. International Journal of Neuroscience, 11, 91-99. http://dx.doi.org/10.3109/00207458009150331
Qiu, C., De Ronchi, D. and Fratiglioni, L. (2007) The Epidemiology of the Dementias: An Update. Current Opinion in Psychiatry, 20, 380-385. http://dx.doi.org/10.1097/YCO.0b013e32816ebc7b
Sacktor, N., Nakasujja, N., Okonkwo, O., Skolasky, R.L., Robertson, K., Musisi, S., et al. (2013) Longitudinal Neuropsychological Test Performance among HIV Seropositive Individuals in Uganda. Journal of NeuroVirology, 19, 48-56. http://dx.doi.org/10.1007/s13365-012-0139-5
Cross, S., Önen, N., Gase, A., Overton, E.T. and Ances, B.M. (2013) Identifying Risk Factors for HIV-Associated Neurocognitive Disorders Using the International HIV Dementia Scale. Journal of NeuroImmune Pharmacology, 8, 1114-1122. http://dx.doi.org/10.1007/s11481-013-9505-1
Nakku, J., Kinyanda, E. and Hoskins, S. (2013) Prevalence and Factors Associated with Probable HIV Dementia in an African Population: A Cross-Sectional Study of an HIV/AIDS Clinic Population. BMC Psychiatry, 13, 126-132. http://dx.doi.org/10.1186/1471-244X-13-126
Waldrop-Valverde, D., Nehra, R., Sharma, S., Malik, A., Jones, D., Kumar, A.M., et al. (2010) Education Effects on the International HIV Dementia Scale. Journal of NeuroVirology, 16, 264-267. http://dx.doi.org/10.3109/13550284.2010.497808
Mukherjee, J., Farmer, P., Nityizonkiza, D., Mccorkle, L., Vanderwarker, C. and Teixeira, P. (2003) Tackling HIV in Resource Poor Countries. BMJ, 327, 1104-1106. http://dx.doi.org/10.1136/bmj.327.7423.1104
Herrera Jr., E., Caramelli, P., Silveira, A.S. and Nitrini, R. (2002) Epidemiologic Survey of Dementia in a Community-Dwelling Brazilian Population. Alzheimer Disease & Associated Disorders, 16, 103-108. http://dx.doi.org/10.1097/00002093-200204000-00007
Prencipe, M., Ferretti, C., Casini, A.R., et al. (1997) Stroke, Disability, and Dementia: Results of a Population Survey. Stroke, 28, 531-536. http://dx.doi.org/10.1161/01.STR.28.3.531
Ravaglia, G., Forti, P., Maioli, F., Sacchetti, L., et al. (2002) Education, Occupation, and Prevalence of Dementia: Findings from the Conselice Study. Dementia and Geriatric Cognitive Disorders, 14, 90-100. http://dx.doi.org/10.1159/000064930
Stern, Y. (2006) Cognitive Reserve and Alzheimer Disease. Alzheimer Disease & Associated Disorders, 20, 112-117. http://dx.doi.org/10.1097/01.wad.0000213815.20177.19
Katzman, R. (1993) Education and the Prevalence of Dementia and Alzheimer’s Disease. Neurology, 43, 13-20. http://dx.doi.org/10.1212/wnl.43.1_part_1.13
Gray, F. (1998) Dementia and Human Immunodeficiency Virus Infection. Journal of Neurology, 154, 2591-2598.
Tozzi, V., Balestra, P., Bellagamba, R., Corpolongo, A., Salvatori, M.F., Visco-Comandini, U., et al. (2007) Persistence of Neuropsychological Deficits Despite Long-Term Highly Active Antiretroviral Therapy in Patients with HIV-Related Neurocognitive Impairment: Prevalence and Risk Factors. Journal of Acquired Immune Deficiency Syndromes, 45, 174-182. http://dx.doi.org/10.1097/QAI.0b013e318042e1ee
Ford, N., Shubber, Z., Pozniak, A., Victoria, M., Doherty, M., Kirby, C., et al. (2015) Comparative Safety and Neuropsychiatric Adverse Events Associated with Efavirenz Use in First-Line Antiretroviral Therapy: A Systematic Review and Meta-Analysis of Randomized Trials. Journal of Acquired Immune Deficiency Syndromes, 69, 422-429.
Grant, I., Sacktor, N. and McArthur, J. (2005) HIV Neurocognitive Disorders. In: Gendelman, H.E., Grant, I., Everall, I.P., et al., Eds., The Neurology of AIDS, Oxford University Press, New York, 357-373.
Letendre, S., Marquie-Beck, J., Capparelli, E., Best, B., Clifford, D., Collier, A.C., et al. (2008) Validation of the CNS Penetration-Effectiveness Rank for Quantifying Antiretroviral Penetration into the Central Nervous System. Archives of Neurology, 65, 65-70. http://dx.doi.org/10.1001/archneurol.2007.31
Letendre, S.L., McCutchan, J.A., Childers, M.E., et al. (2004) Enhancing Antiretroviral Therapy for Human Immunodeficiency Virus Cognitive Disorders. Archives of Neurology, 56, 416-423. http://dx.doi.org/10.1002/ana.20198
Tozzi, V., Balestra, B., Salvatori, M.F., et al. (2008) Changes in Cognition during HAART: Comparison of Two Different Scoring Systems to Measure Antiretroviral Drug Efficacy on HIV-Dementia. Proceedings of the 15th Conference on Retroviruses and Opportunistic Infections, Boston, 3-6 February 2008.
Lanoy, E., Bentata, M., Guiguet, M., et al. (2007) Improvement of Survival after a Neurological AIDS Defining Event over Time. Proceedings of the 11th European AIDS Conference, Madrid, 24-27 October 2007.